SpaceX Scrubs Starship Test Flight Eyes Friday Launch for Starship V3 Debut European AI Stocks Surge Over 100 Gains Attract Investor Attention Amid Global AI Race Mercury Fintech Firm Achieves 52 Billion Valuation After Latest Funding Round Evercore ISI Raises Price Target on Cummins Inc CMI Wall Street Mixed as Oil Prices Slide on Iran Deal Hopes Micron Surges 56 GlobalFoundries Falls 9 UK Bank Holiday Travel Surge and Warm Weather May Boost Consumer Spending APH Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction NBIX Q1 2026 Earnings Strong EPS Beat Driven by Operational Strength UUU Q4 2024 Earnings Widened Loss Amidst Challenging Market Conditions LUMN Q1 2026 Earnings Significant EPS Miss Reflects Ongoing Transformation Challenges Milestone Pharmaceuticals Q1 2026 Earnings ClinicalStage Biotech Reports Wider Loss Than Expected Paramount Skydance Corporation PSKY Q1 2026 Earnings EPS Surges Past Expectations Stock Rises Baozun Inc BZUN Dips 272 as Stock Nears Key Support Zone Medicinova Inc MNOV Edges Higher on Modest Volume Faces Key Resistance at 141 Aurelion Inc AURE Bounces from Support Zone Eyes 264 Resistance CarPartscom PRTS Holds Steady Near Support Levels as Modest Uptick Signals Caution Atomera ATOM Surges Over 31 as Semiconductor Technology Stock Gains Momentum American Express National Bank Review HighYield Accounts Without Overdraft or Monthly Fees Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 Granite Ridge Resources GRNT Slips 12 as Oil Price Headwinds Test Support at 469 BURU Q3 2023 Earnings PreRevenue Loss of 014 per Share as Strategic Developments Underway QRHC Q1 2026 Earnings EPS Misses Estimates Stock Gains Despite Loss RKT Q1 2026 Earnings EPS Surpasses Estimates by 256 Amid Challenging Market FLY Q1 2026 Earnings EPS Beats Estimates as PreRevenue Aerospace Company Advances LENZ Q1 2026 Earnings WiderthanExpected Loss as Pipeline Development Drives Costs UEIC Q1 2026 Earnings EPS Misses Estimates amid Challenging Conditions Minerva Neurosciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Faces Challenges